Compare ADIL & AEHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADIL | AEHL |
|---|---|---|
| Founded | 2010 | 1993 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building Materials |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 6.2M |
| IPO Year | 2017 | 2009 |
| Metric | ADIL | AEHL |
|---|---|---|
| Price | $1.65 | $1.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $37.50 | N/A |
| AVG Volume (30 Days) | 94.4K | ★ 7.6M |
| Earning Date | 03-06-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.13 | $0.34 |
| 52 Week High | $3.67 | $8.41 |
| Indicator | ADIL | AEHL |
|---|---|---|
| Relative Strength Index (RSI) | 42.99 | 43.03 |
| Support Level | $1.61 | $1.07 |
| Resistance Level | $2.08 | $1.46 |
| Average True Range (ATR) | 0.15 | 0.17 |
| MACD | -0.06 | -0.08 |
| Stochastic Oscillator | 3.85 | 4.65 |
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.